Garrison Institute on Aging | Texas Tech University Health Sciences Center
TTUHSC students walking through Lubbock campus courtyard.


Our mission is to promote healthy aging and address health issues of the aging population through cutting edge research and innovative educational and community outreach programs.  The Garrison Institute on Aging (GIA) conducts and facilitates research into investigating the causes of neurodegenerative disease and dementias such as Alzheimer's and related brain dysfunctions.  The GIA's educational programs for the community on aging-related health issues such as dementias and mental health, preventative medicine and identifying challenges impacting the geriatric population. 

Our vision is to serve as the leader and central hub within Texas Tech University Health Sciences Center (TTUHSC) for collaborative initiatives in research, interdisciplinary education and community outreach related to healthy aging, aging-related disorders, brain diseases and dementias and mental health through a combination of GIA-based programs and collaborations with colleagues across TTUHSC and beyond.  The GIA plans to continue and grow its more than 40 collaborative projects involving preclinical and clinical studies on aging-related conditions and brain disease.

Mr. Garrison


In 1999, TTUHSC leadership identified aging as a strategic priority for the 21st Century. The Board of Regents approved the establishment of the Institute for Healthy Aging which was renamed in February 2005, in honor of Mildred and Shirley L. Garrison. 

Executive Director

GIA advances and disseminates knowledge about healthy aging and aging related health issues, including neurodegenerative diseases such as Alzheimer’s, through basic and translational research. GIA houses a newly created behavioral testing and electrophysiology facility, molecular biology laboratories, brain bank, and a longitudinal epidemiological data base on aging in a multiethnic adult sample from rural communities of West Texas (Project FRONTIER).

Aging-related nervous system dysfunctions represent a major health care problem in this country and worldwide. The better understanding of disease mechanisms is needed to develop novel and improved diagnostic and therapeutic tools and strategies. GIA provides the infrastructure and expertise for collaborative efforts of basic scientists and clinicians from various disciplines and specialties in the area of aging-related and neurodegenerative disorders.

Thank you for visiting our website. Please feel free to contact the GIA team headed by Dr. Neugebauer with any questions or for more information. 


Volker Neugebauer, M.D., Ph.D.  (Learn more about Dr. Neugebauer
Executive Director and Chief Scientific Officer, Garrison Institute on Aging
Mildred and Shirley L. Garrison Chair in Aging
Professor and Chair, Pharmacology and Neuroscience Director
Center of Excellence for Translational Neuroscience and Therapeutics 
Giles C. McCray Endowed Chair in Addiction Medicine

Connect With Us

TTUHSC Garrison Institute on Aging

6630 Quaker Ave, Suite E, Lubbock, Texas 79413

Phone: (806) 743-7821



University Distinguished Faculty at the TTUHSC. This honor acknowledges Dr. Neugebauer’s outstanding contributions in at least one of the following areas- teaching, research and/or service.  His achievements have brought distinction to TTUHSC and serve as an exemplar for other faculty, staff and students.


Congrats to Dr. Jonathan Singer, Ph.D. and Dr. Volker Neugebauer, M.D. on the Diversity, Equity, and Inclusion Grant entitled Implementing Individual Mental Health Treatment and Respite for Hispanic Informal Caregivers of Individuals with Dementia being funded.

From Bedside To Bench

Dr. Volker Neugebauer is subject of a new piece in Pulse Magazine. Click here to read more about Dr. Neugebauer's journey to now, as Executive Director of the GIA.

Grant Awarded

Dr. Josh Lawrence has been awarded an R01 grant from the National Institutes of Health.  This 5-year project is titled "Transcriptional Dysfunction in Dentate Gyrus Cell Types: Roles of Retinoic Acid Responsive Genes in Protection Against Alzheimer's Disease Pathogenesis."  This project is anticipated to receive $1,872,220.

Grant Awarded!

Dr. Josh Lawrence has
been awarded an RO1 grant from the National Institutes of Health. This five year project is titled "The hippocampal dentate gyrus in aging and Alzheimer's disease: boosting transcription of retinoic acid-sensitive genes through vitamin A supplementation and HDAC inhibition." This project is anticipated to receive 3,184.045.